or Try an Advanced Search...

    Technical Analysis for ONVO - Organovo Holdings, Inc.

    Grade Last Price % Change Price Change
    F 0.34 -2.86% -0.01
    ONVO closed up 2.58 percent on Wednesday, November 20, 2024, on 5.95 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ONVO trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup -2.86%
    Volume Surge Other -2.86%
    Calm After Storm Range Contraction -2.86%
    Lower Bollinger Band Walk Weakness -2.86%
    Outside Day Range Expansion -2.86%
    Wide Bands Range Expansion -2.86%
    Lower Bollinger Band Touch Weakness -2.86%
    New 52 Week Closing Low Bearish -0.35%
    Lower Bollinger Band Walk Weakness -0.35%
    Wide Bands Range Expansion -0.35%
    Older End-of-Day Signals for ONVO ...

       Recent Intraday Alerts

    Alert Time
    Lower Bollinger Band Support 41 minutes ago
    1.5x Volume Pace about 3 hours ago
    Down 5% about 3 hours ago
    Down 3% about 3 hours ago
    Fell Below Lower Bollinger Band about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ONVO Chart by TradingView
    Basic chart:

    Profile

    Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company's 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. The company was founded in 2007 and is based in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biotechnology Biology Synthetic Biology Medical Applications Novogen Printing Technology Tissue Engineering

    Is ONVO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases
    Nov 11 ONVO Releases Encouraging Quarterly Results
    Oct 25 Organovo Holdings files to sell common stock, warrants
    Aug 6 ONVO Announces Earnings and Notes Potential for Acquisition
    Jul 18 Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July
    Jul 16 Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis
    Jun 4 ONVO Increases Cash and Improves Prospects
    May 21 Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease
    See more ONVO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.74
    52 Week Low 0.3154
    Average Volume 98,563
    200-Day Moving Average 0.76
    50-Day Moving Average 0.45
    20-Day Moving Average 0.41
    10-Day Moving Average 0.38
    Average True Range 0.05
    RSI (14) 37.11
    ADX 12.43
    +DI 15.82
    -DI 17.19
    Chandelier Exit (Long, 3 ATRs) 0.37
    Chandelier Exit (Short, 3 ATRs) 0.46
    Upper Bollinger Bands 0.49
    Lower Bollinger Band 0.33
    Percent B (%b) 0.11
    BandWidth 38.27
    MACD Line -0.03
    MACD Signal Line -0.02
    MACD Histogram -0.0046
    Fundamentals Value
    Market Cap 3.51 Million
    Num Shares 10 Million
    EPS -2.15
    Price-to-Earnings (P/E) Ratio -0.16
    Price-to-Sales 41.53
    Price-to-Book 1.07
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.45
    Resistance 3 (R3) 0.45 0.42 0.44
    Resistance 2 (R2) 0.42 0.40 0.42 0.43
    Resistance 1 (R1) 0.39 0.38 0.40 0.38 0.42
    Pivot Point 0.35 0.35 0.36 0.35 0.35
    Support 1 (S1) 0.32 0.33 0.34 0.32 0.28
    Support 2 (S2) 0.28 0.31 0.28 0.27
    Support 3 (S3) 0.25 0.28 0.26
    Support 4 (S4) 0.25